MCNAMARA KEVIN J 4
4 · CHEMED CORP · Filed May 6, 2025
Insider Transaction Report
Form 4
CHEMED CORPCHE
MCNAMARA KEVIN J
Directorpresident and CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy with tandem tax withholding)
2025-05-05$471.74/sh−10,000$4,717,400→ 207,487 totalExercise: $471.74Exp: 2025-10-29→ Capital Stock (10,000 underlying) - Sale
Capital Stock
2025-05-05$576.45/sh−1,500$864,675→ 101,197 total - Exercise/Conversion
Capital Stock
2025-05-05$471.74/sh+10,000$4,717,400→ 111,679 total - Tax Payment
Capital Stock
2025-05-05$574.02/sh−8,982$5,155,848→ 102,697 total
Footnotes (3)
- [F1]Payment of purchase price and tax obligation on stock option exercise.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.98 to $579.54. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
- [F3]Vesting in three equal annual installments commencing 10/29/2021